Rast, Catherine E.
Musci, Rashelle
Abramowitz, Jonathan S.
Nestadt, Gerald
Nestadt, Paul
Kimmel, Mary C.
Dibbs, Tracey
Osborne, Lauren M.
Samuels, Jack
Krasnow, Janice
Storch, Eric A.
Funding for this research was provided by:
National Institute of Mental Health (R01MH118249, R01MH118261)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103555)
Article History
Received: 8 August 2024
Accepted: 18 December 2024
First Online: 2 January 2025
Change Date: 27 March 2024
Change Type: Update
Change Details: The original online version of this article was revised because one author was inadvertently left off of the submitted title page despite having contributed substantively to this research
Change Date: 1 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00737-025-01580-3
Declarations
:
: Dr. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and NIH. He was a consultant for Brainsway and Biohaven Pharmaceuticals in the past 24 months. He owns stock less than $5000 in NView (for distribution of the Y-BOCS and CY-BOCS). He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, Routledge, and Jessica Kingsley. Dr. Abramowitz, Dr. Nestadt, Dr. Krasnow, Ms. Rast and Ms. Dibbs have no disclosures to report.
: Informed consent was obtained from all participants involved in this study. This study received IRB approval.